IO Biotech Future Growth
Future criteria checks 0/6
IO Biotech is forecast to grow earnings and revenue by 6.7% and 23.9% per annum respectively. EPS is expected to grow by 24.8% per annum. Return on equity is forecast to be -87231% in 3 years.
Key information
6.7%
Earnings growth rate
24.8%
EPS growth rate
| Biotechs earnings growth | 24.1% |
| Revenue growth rate | 23.9% |
| Future return on equity | -87,231.0% |
| Analyst coverage | Low |
| Last updated | 08 Mar 2024 |
Recent future growth updates
Recent updates
We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Feb 10
We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Jun 15We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Jan 20IO Biotech names new CFO
Oct 13We're Keeping An Eye On IO Biotech's (NASDAQ:IOBT) Cash Burn Rate
Sep 27IO Biotech GAAP EPS of -$0.64
Aug 11We're Keeping An Eye On IO Biotech's (NASDAQ:IOBT) Cash Burn Rate
Jun 14We Think IO Biotech (NASDAQ:IOBT) Needs To Drive Business Growth Carefully
Feb 25Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 10,122 | -139 | -94 | N/A | 5 |
| 12/31/2025 | 2 | -130 | -100 | N/A | 4 |
| 12/31/2024 | N/A | -105 | -88 | N/A | 4 |
| 12/31/2023 | N/A | -86 | -72 | -72 | N/A |
| 9/30/2023 | N/A | -80 | -62 | -61 | N/A |
| 6/30/2023 | N/A | -74 | -59 | -59 | N/A |
| 3/31/2023 | N/A | -71 | -54 | -54 | N/A |
| 12/31/2022 | N/A | -71 | -60 | -60 | N/A |
| 9/30/2022 | N/A | -74 | -67 | -66 | N/A |
| 6/30/2022 | N/A | -65 | -62 | -61 | N/A |
| 3/31/2022 | N/A | -87 | -58 | -58 | N/A |
| 12/31/2021 | N/A | -75 | -41 | -41 | N/A |
| 9/30/2021 | N/A | -56 | -25 | -24 | N/A |
| 6/30/2021 | N/A | -54 | -18 | -18 | N/A |
| 3/31/2021 | N/A | -17 | -11 | -11 | N/A |
| 12/31/2020 | N/A | -15 | -10 | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IOBT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IOBT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IOBT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IOBT is forecast to have no revenue next year.
High Growth Revenue: IOBT is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IOBT is forecast to be unprofitable in 3 years.